Northland Biotech to Showcase Gene Therapy Breakthrough Sedoming Injection at China Pharma Trade Fair in Guangzhou

"On the 15th day of the fourth lunar month, Xiaoman arrives, when all things begin to flourish modestly." On May 21st, with the arrival of Xiaoman, the vitality of life bursts forth and everything in nature grows luxuriantly, filling the air with the joy of an impending harvest. During this hopeful and vibrant season, the 90th China Pharmaceutical Trade Fair will also grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou. As a company deeply rooted in the cell and gene therapy (CGT) field,Leading EnterpriseThe company, Beijing Northland Biotechnology Co., Ltd., has long been ready to make its mark. We will proudly unveil our blockbuster products.Twenty YearsThe Precipitation of Scientific Research Strength, forBiologicalThe innovative development of the pharmaceutical industry injects powerful vitality. We look forward to meeting you in Guangzhou, joining hands to write a new chapter in the development of the pharmaceutical industry, and jointly promoting China's cell and gene therapy pharmaceutical industry towards new prosperity!

Cedomidine Injection-As a therapeutic biological productClass 1 new drug, its marketing application has been accepted.About toStartLower Extremity Ischemic DiseaseA New Chapter in the Field of Gene Therapy! We sincerely invite you to visit our booth (Booth No.:2.1 H39), Take a close look at this productHeavyweight Product, and explore cooperation opportunities with us. There are alsoExquisite Commemorative GiftsLooking forward to exchanging with you in depth!

• National Major Achievements: As a significant achievement of the National Key New Drug Creation Projects during the 11th and 13th Five-Year Plans, it carries the expectations of pharmaceutical innovation in China and demonstrates strong research and development capabilities.

• Paragon of High-End Biologics: Belongs to therapeutic biological productsClass Ⅰ, representing the forefront of the biopharmaceutical field;

• New Breakthrough in Gene Therapy: As a gene therapy drug, it has opened up a completely new path for the treatment of related diseases;

• Patent Protection: Owns exclusive invention patents, ensuring the uniqueness and innovation of the products, standing out in the market competition.

• Exhibition Time：May 21 - 23, 2025

• Exhibition Address: China Import and Export Fair Exhibition Hall (Guangzhou)

Here, you will gain insight into the latest developments in the pharmaceuticals industry, exchange ideas with numerous professionals, and spark innovation.！

Our Company's Booth:Booth No.2.1 H39

Whether you are a newcomer or an old hand, remember this booth number.2.1 H39 , weLooking forward to itYour arrival!

During the exhibition, the first China Pharmaceutical Ecosystem Restructuring Forum will be grandly held. The forum focuses on the restructuring of the industry ecosystem under the background of centralized procurement, and delves into new paths for industrial transformation around new tracks such as private healthcare, e-commerce, and retail. Beijing Northland Biotechnology Co., Ltd., with its strong accumulation in gene therapy drug research and commercialization, will engage in discussions with industry peers.Commercialization Pathways and Collaboration Mechanisms for Cell and Gene Therapy DrugsAt that time, you are welcome to come to the scene, listen to the cutting-edge viewpoints, grasp the pulse of industry development, and jointly explore the future direction of the pharmaceuticals industry.

• Speech Time:May 21, 2025, 14:50 - 15:20

• Topic of the speech: Reflections on the Commercialization Path and Cooperation Mechanism of Gene Therapy Drugs

• Speaker:Vice President of the Company Zhao Lei

Venue: China Import and Export Fair Exhibition HallMeeting Room 3, Area A

Beijing Northland Biotechnology Co., Ltd. (Stock Code: 430047), established in 2004, has been deeply engaged in the CGT sector, with its R&D pipeline primarily distributed across fields such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic conditions.

The company is a key high-tech enterprise under the National Torch Program, a Beijing-based research and development institution, the Beijing Engineering Research Center for Plasmid DNA Gene Therapy Drugs, an international science and technology cooperation base in Beijing, a G20 innovation-leading enterprise in Beijing's biopharmaceuticals industry, and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Beijing. Its core product, Cedominogene Plasmid Injection, is China’s first plasmid DNA gene therapy drug for treating severe lower limb ischemia and is about to be approved.

The company upholds the tenet of "Creating Value, Serving Health" and is committed to becoming a leading enterprise in China's gene therapy field, making positive contributions to the progress of China's pharmaceutical industry and human health.

Beijing Northland Biotechnology Co., Ltd. focuses on cell and gene therapy (CGT) and recombinant protein drug field，Therapeutic biological products coverClass 1, Class 2, and Class 3, targeting severe lower limb ischemic diseases, osteoarthritis, acute myocardial infarction, etc.FieldCedoming Injection for Limb Ulcers Caused by Severe Lower Extremity Ischemic DiseaseIndications, marketing application has been accepted, expectedApproved in 2025。The indication for sedominogene injection in resting pain has been completed.Phase 3 Clinical Trial.

"Victory belongs to those who share the same aspirations, and prosperity comes to those who brave the storm together." Beijing Northland Biotechnology Co., Ltd. extends a sincere invitation to agents across China, looking forward to in-depth discussions and negotiations with you. Whether you are a seasoned industry partner or an emerging force, we are willing to join hands with you, share market opportunities, and achieve mutual benefits. Let us take this pharmaceutical trade fair as a starting point and jointly draw a grand blueprint for the pharmaceutical industry!

Group Headquarters: Kaituo Road, Shangdi, Haidian District, Beijing, ChinaRoom A406, No. 5
Phone:010 - 82890893
Marketing Center: Tianmu West Road, Jing'an District, ShanghaiRoom 1101, Building 99, Lufeng Sky Center
Phone:021 - 52927896
Email:market@northland-bio.com
Official Website:www.northland-bio.com 

1.Subway Travel:Take Subway Line 8 and exit at Exit A of Xingangdong Station to directly reach Area A of the Canton Fair Exhibition Hall.

◆Departure from the airport:North Airport Station / South Airport Station: Take Line 3 (North Extension), board at North Airport Station (Terminal 2) or South Airport Station (Terminal 1), transfer to Line 3 at Tiyu Xilu Station, then transfer to Line 8 at Ke Village Station, and get off at Xingang East Station (Area A of the Canton Fair exhibition hall).

◆Guangzhou Railway Station:Take Metro Line 2 (towards Guangzhou South Station) to Changgang Station, transfer to Line 8 (towards Wansheng Station), and exit at Xingangdong Station (Exit A).

◆Guangzhou East Railway Station:Take Metro Line 3 (towards Panyu Square Station) to Kecun Station, transfer to Line 8 (towards Wansheng Station), and exit at Xingangdong Station Exit (Area A);

◆Guangzhou South Station：Take Subway Line 2 (towards Jiahe Wanggang Station) to Changgang Station, transfer to Line 8 (towards Wanshengwei Station), and get off at Xingang East Road Station to reach Exhibition Area A.

2.Taxi:Navigate to Gate 5, Area A of the Canton Fair Exhibition Hall (taxi pick-up lane on Zhanchang Middle Road).

3. Self-driving:Navigate to the A Area, Gate 8 of the Canton Fair Exhibition Hall, and proceed straight into the A Area underground parking lot.

Looking forward to meeting you in Guangzhou and attending this wonderful event in the pharmaceuticals industry together!!!